Valerio Therapeutics (C4X) Q4 2024 Earnings Report
DE:C4X Q4 2024 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.07
DE:C4X Q4 2024 Revenue Results
- Actual Revenue
- EUR 126.00K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -93.00%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 07/09/2025
- Time
- TBA
- Conference Call
- Wednesday, July 9, 2025
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C4X Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Oct 29, 2025 | 2025 (Q2) | ―- | -0.07 | ― | |
| Jul 09, 2025 | 2024 (Q4) | ―-0.00 | -0.07 | 98.51% (+0.07) | |
| Sep 30, 2024 | 2024 (Q2) | ―-0.07 | -0.1 | 33.00% (+0.03) | |
| Apr 30, 2024 | 2023 (Q4) | ―-0.06 | -0.07 | 23.29% (+0.02) | |
| Sep 28, 2023 | 2023 (Q2) | ―-0.10 | -0.11 | 9.09% (+0.01) | |
| Apr 24, 2023 | 2022 (Q4) | ―-0.07 | -0.01 | -461.54% (-0.06) | |
| Sep 13, 2022 | 2022 (Q2) | ―-0.11 | -0.06 | -96.43% (-0.05) | |
| Apr 06, 2022 | 2021 (Q4) | ―-0.01 | -0.05 | 74.00% (+0.04) | |
| Jul 29, 2021 | 2021 (Q2) | ―-0.06 | 0.06 | -187.50% (-0.12) | |
| Apr 21, 2021 | 2020 (Q4) | ―-0.05 | -0.41 | 87.83% (+0.36) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
